Our mission
Providing custom tailored, high quality preclinical services to prime your drugs for success.
We offer expert solutions for optimal preclinical testing
Our agent in Korea
On this Word Osteoporosis Day let's all be reminded that healthy life-style, timely diagnosis and effective treatment are the key to Build Better Bones!
Precision-cut lung slices (PCLS) offer an opportunity for the development of ex vivo IPF preclinical tools for the validation of novel anti-fibrotic therapies
The TNFΔAREhTNFR1KI model, is an ideal tool for drug discovery and development of biologics and small molecules targeting TNF and hTNFR1 in Crohn’s-like ileitis.
OUR CLIENTS SAY
"Our company had a pleasant experience of productive collaboration with Biomedcode s.a. in 2015. We would like to especially highlight the high quality of the study protocol preparation and report writing as well as efficient communication with Biomedcode’s CEO. We greatly appreciate your professionalism and looking forward to our future collaboration."
"We have several collaborations with Biomedcode, their scientific and efficient experiment schedules made each collaboration accomplished according to plan. From Biomedcode, we obtained convincing study reports and detailed records, which saved a lot of time for us in whole pre-clinical stage. We believe contracting professional works to such a professional and sophisticated group is a wise choice."
"It was a great pleasure working with Biomedcode that exhibited great expertise in preclinical testing and handled all the steps of the study with great professionalism always abiding by the terms of the agreement and always staying in close communication with us making this a very productive collaboration."
"The authors acknowledge the role of BioMedCode relating to studies involving the human Tg197 TNF transgenic mouse model of polyarthritis in identifying sensitive study designs to optimally address efficacy comparability in this well-establish and characterized disease model"
"…that was a pleasure to work with Biomedcode. Perfect in every aspect: study design, correspondence, preparation of the report, timing, additional discussions and etc. Biomedcode was recommended to us by the other company and after working with them we highly recommend Biomedcode to everyone."
Clients
Research Funding
Collaborators
Exploring the interplay between inflammation and senescence in the context of combination anti-arthritic therapeutic approaches.
Introducing a novel mouse model to explore the role of human RANKL in breast cancer and assemble a preclinical tool for anticancer drug evaluation.
We are proud to have contributed in the project of repurposing the antipsychotic drug amisulpride for the treatment of arthritis